非吸烟肺腺癌肿瘤微环境不良预后免疫特征
研究通过免疫组化多色染色(n=234)和基因表达分析(n=58)全面刻画非小细胞肺癌免疫微环境。发现表达IFN-γ和颗粒酶的活化CD8+ T细胞高浸润与腺癌以外患者术后生存相关,而CD8+ T细胞积聚在腺癌尤其非吸烟者中为更差预后因素。非吸烟肺腺癌中CD8+ T细胞活化显著减少,免疫调节性CD8+FOXP3+和免疫失调性CD8+GATA3+ T细胞增多,CCR4+FOXP3+调节性T细胞与CCL17+CD163+M2样巨噬细胞协同显著积聚。
要点
- 活化CD8+ T细胞高浸润与腺癌以外患者术后生存相关
- CD8+ T细胞积聚在腺癌尤其非吸烟者中为更差预后因素
- 非吸烟肺腺癌中CD8+ T细胞活化显著减少,免疫调节基因高表达
核心结论
- 非吸烟肺腺癌中特征性免疫细胞可能通过营造免疫抑制微环境促进肿瘤进展。
- 研究结果可能有助于完善非小细胞肺癌个体化免疫治疗包括免疫检查点阻断治疗的策略。
研究设计与样本
- 采用替代计数法和多色染色法进行免疫组化评估免疫细胞(n=234)。
- 采用基因分析方法评估免疫相关基因表达(n=58)。
主要发现
- 表达干扰素γ(IFN-γ)和颗粒酶的活化CD8+ T细胞高浸润与腺癌以外患者术后生存相关。
- CD8+ T细胞积聚在腺癌尤其非吸烟者中被确定为更差预后因素。
- 在该微环境中浸润CD8+ T细胞活化显著减少,多种免疫调节基因高表达。
- 非吸烟者腺癌中潜在免疫调节性CD8+FOXP3+ T细胞和免疫失调性CD8+GATA3+ T细胞增多。
- 表达趋化因子受体4(CCR4)的CD4+FOXP3+调节性T细胞与表达趋化因子配体(CCL17)的CD163+M2样巨噬细胞在非吸烟者腺癌中协同且显著积聚。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We have previously demonstrated that the prognostic significance of tumour-infiltrating CD8+ T cells significantly differs according to histological type and patient smoking habits in non-small cell lung cancer (NSCLC). This work suggested that infiltrating CD8+ T cells may not be activated sufficiently in the immunosuppressive microenvironment in non-smokers with adenocarcinoma. To understand the immunogenic microenvironment in NSCLC, we characterised immune cells comprehensively by performing an immunohistochemical evaluation using an alternative counting method and multicolour staining method (n = 234), and assessed immune-related gene expression by using genetic analytical approaches (n = 58). We found that high infiltration of activated CD8+ T cells expressing interferon gamma (IFN-γ) and granzyme was correlated with postoperative survival in patients with non-adenocarcinoma. On the contrary, CD8+ T-cell accumulation was identified as a worse prognostic factor in patients with adenocarcinoma, particularly in non-smokers. Infiltrating CD8+ T cells were significantly less activated in this microenvironment with high expression of various immunoregulation genes. Potentially immunoregulatory CD8+ FOXP3+ T cells and immunodysfunctional CD8+ GATA3+ T cells were increased in adenocarcinoma of non-smokers. CD4+ FOXP3+ regulatory T cells expressing chemokine receptor-4 (CCR4)- and chemokine ligand (CCL17)-expressing CD163+ M2-like macrophages also accumulated correlatively and significantly in adenocarcinoma of non-smokers. These characteristic immune cells may promote tumour progression possibly by creating an immunosuppressive microenvironment in non-smoking patients with lung adenocarcinoma. Our findings may be helpful for refining the current strategy of personalised immunotherapy including immune-checkpoint blockade therapy for NSCLC.
引用
- Kinoshita T, Kudo-Saito C, Muramatsu R, et al. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. Eur J Cancer. 2017. PMID: 28950145. doi:10.1016/j.ejca.2017.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。